WellGen

North Brunswick, United States Founded: 1997 • Age: 29 yrs
Medical foods are developed using nutrigenomics and bioinformatics models.
Request Access
Report Incorrect Data
Annual revenue - Latest available
Total funding $12.5M 2 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About WellGen

WellGen is a company based in North Brunswick (United States) founded in 1997. WellGen has raised $12.5 million across 2 funding rounds from investors including Amphion Innovations. WellGen operates in a competitive market with competitors including Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.

  • Headquarter North Brunswick, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Wellgen, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research → →
Healthcare → Nutrition, Wellness & Lifestyle Health → →
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $12.5 M (USD)

    in 2 rounds

  • Latest Funding Round
    $9.5 M (USD), Series C

    Oct 29, 2007

  • Investors
    Amphion Innovations
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of WellGen

WellGen has successfully raised a total of $12.5M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $9.5 million completed in October 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series C — $9.5M
  • First Round

    (20 Feb 2006)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2007 Amount Series C - WellGen Valuation

investors
Amphion Innovations
Feb, 2006 Amount Series B - WellGen Valuation

investors
Amphion Innovations

Investors in WellGen

WellGen has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Amphion Innovations.

All
Venture Fund
Investor Description Founded Year Domain Location
Amphion Innovations
Tech and life sciences focused VC firm investing in geographies such as the US and the UK
Founded Year Domain Location

Investments & Acquisitions by WellGen

Investments

Financial Statements - WellGen

Wellgen Comparisons

+
Add Comparison
Available on Premium

Competitors of WellGen

WellGen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.

Company Name Domain Founded year HQ Location Description
Insitro
domain founded_year HQ Location
An AI-enabled platform is developed for infectious disease treatment.
BridgeBio
domain founded_year HQ Location
Therapeutics for genetic diseases are developed through targeted interventions.
ATAI
domain founded_year HQ Location
A biopharmaceutical company accelerating innovative mental health treatments.
Forge Biologics
domain founded_year HQ Location
Gene therapies for rare diseases are developed to treat patients.
Spark Therapeutics
domain founded_year HQ Location
Gene therapies for rare diseases including retinal dystrophies are developed.
Caribou Biosciences
domain founded_year HQ Location
Provider of cell therapies to treat cancer and hematologic conditions

Latest news on Wellgen

WellGen, Inc. Completes $9.5 Million Series C Financing
Biospace • 18 years ago

Frequently Asked Questions about WellGen

WellGen was founded in 1997 and raised its 1st funding round 9 years after it was founded.

WellGen is headquartered in North Brunswick, United States. It is registered at North Brunswick, New Jersey, United States.

WellGen is a funded company, having raised a total of $12.5M across 2 funding rounds to date. The company's 1st funding round was a Series B of $3M, raised on Feb 20, 2006.

Founded in 1997, WellGen operates in the nutrigenomics sector from North Brunswick, United States. Proprietary medical foods are created through in-house expertise in natural product chemistry and gene expression analysis. The Alignomxa bioinformatics model is utilized to identify optimal therapeutic areas for a pipeline of natural products. Opportunities in functional foods, beverages, and dietary supplements are also pursued.

WellGen's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.

WellGen has 1 investor. Key investors include Amphion Innovations.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available